University of Wolverhampton, Research Institute in Healthcare Science, UK
Dr Wang obtained a Bachelor degree in Medicine from Hebei United University, Tangshan, China and MD from Beijing Postgraduate Medical School of PLA, Beijing, China. In 1992, Dr Wang moved to UK and worked in the Department of Experimental Hematology as a visiting fellow. He gained his PhD degree in 1997 in the Manchester Metropolitan University, UK. After his PhD training, Dr Wang worked in University of Aberdeen and Beatson Institute for Cancer Research, UK, between 1999 and 2005 as a research fellow and senior research scientist. In May 2005, He was appointed a readership in Research Institute in Healthcare Science, University of Wolverhampton.
Dr Wang’s research interests are focused on study of cancer cell chemoresistance. He is interested in the relationship between hypoxia-triggered NF-κB pathway activation, cancer stem-like cells and de novo/acquired chemoresistance. His group has been trying to identify some clinically available medicine with inhibiting effect on NF-κB pathway and cancer stem-like cells to target cancer cells and and sensitise cancer cells to conventional anticancer drugs.